Leadership Overview
Neuronetics has 4 executives leading key functions including strategy, revenue generation, technology, and medical affairs.
Driven by innovation in mental health, Neuronetics is dedicated to advancing TMS treatment, providing unparalleled support to practices, and solidifying its position as the industry leader in depression therapy.
Driven by innovation in mental health, Neuronetics is dedicated to advancing TMS treatment, providing unparalleled support to practices, and solidifying its position as the industry leader in depression therapy.
Leadership Roles at Neuronetics
Daniel Reuvers - President & Chief Executive Officer
Daniel Reuvers, the President & Chief Executive Officer at Neuronetics, directs the company's overall strategic vision and operational execution. Reuvers guides the organization's expansion within the mental health sector, focusing on solidifying NeuroStar's position as the leading TMS treatment for depression. This leadership involves driving market penetration and ensuring the company's continued growth through innovation and strategic partnerships. The President & Chief Executive Officer oversees all departments, ensuring alignment with the company's mission to provide superior mental health solutions. Reuvers's focus remains on enhancing the clinical evidence supporting NeuroStar and expanding its accessibility to patients nationwide. The executive's mandate includes fostering a culture of excellence and driving the company's financial performance. Daniel Reuvers ensures the company maintains its competitive edge in the rapidly evolving field of neuromodulation therapies.
Sara Grubbs - Chief Revenue Officer
Sara Grubbs, the Chief Revenue Officer at Neuronetics, spearheads all revenue-generating activities and commercial strategies. Grubbs directs the sales, marketing, and business development functions, ensuring aggressive growth targets are met and exceeded. This leadership involves optimizing the sales funnel and expanding market reach for NeuroStar Advanced Therapy. The Chief Revenue Officer works closely with the President & Chief Executive Officer to align commercial efforts with the company's strategic objectives. Grubbs's expertise is critical in driving practice success through exceptional ongoing support and maximizing the adoption of TMS technology. By cultivating strong relationships with healthcare providers, Sara Grubbs ensures the widespread availability of effective depression treatment. The executive's responsibilities include developing innovative pricing models and go-to-market strategies that reinforce Neuronetics's industry leadership. Sara Grubbs's efforts directly contribute to the company's financial health and its mission to improve mental well-being.
Corey Anderson - Chief Technology Officer
Corey Anderson, the Chief Technology Officer at Neuronetics, architects and oversees the company's technological infrastructure and innovation pipeline. Anderson drives the development and enhancement of NeuroStar's TMS technology, ensuring its continued leadership in clinical evidence and efficacy for depression treatment. This role involves managing research and development efforts, safeguarding intellectual property, and ensuring the scalability and reliability of the company's technological solutions. The Chief Technology Officer collaborates with other executive leaders to integrate cutting-edge advancements into the product roadmap. Corey Anderson's technical leadership is paramount in maintaining NeuroStar's competitive advantage and expanding its capabilities. The executive's focus includes exploring new applications for TMS and optimizing the user experience for both practices and patients. By championing technological excellence, Corey Anderson supports Neuronetics's mission to deliver advanced mental health therapies.
Geoffrey Grammer - Vice President, Chief Medical Officer
Geoffrey Grammer, the Vice President, Chief Medical Officer at Neuronetics, provides critical medical and scientific leadership for NeuroStar Advanced Therapy. Grammer oversees the clinical strategy, ensuring the highest standards of patient care and treatment efficacy are maintained. This leadership involves guiding clinical research initiatives, interpreting complex data, and advising on the medical implications of the company's TMS technology for depression. The Vice President, Chief Medical Officer collaborates with the research and development teams to enhance the clinical evidence base supporting NeuroStar. Geoffrey Grammer's insights are essential for validating the technology's effectiveness and expanding its therapeutic applications. The executive's role includes engaging with the medical community and ensuring compliance with all relevant healthcare regulations. Geoffrey Grammer's dedication to advancing mental health treatment underpins Neuronetics's commitment to patient well-being.
Explore Leadership Teams in Manufacturing
Medtronic is a global medical technology company that designs, manufactures, and sells device-based medical therapies across multiple segments including cardiac rhythm management, spinal solutions, neurological treatments, vascular interventions, diabetes care, cardiac surgery, and ear, nose and throat products. Founded in 1949, the company operates worldwide with a comprehensive portfolio of innovative medical devices and therapies aimed at treating chronic diseases and health conditions. Medtronic serves healthcare systems, clinicians, and patients in more than 150 countries through its extensive global network, advancing its mission to alleviate pain, restore health, and extend life through technology.
Company Leadership WH
AR
DW
Zimmer Biomet Holdings, Inc., together with its subsidiaries, provides musculoskeletal healthcare products and solutions in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company operates through four segments: Americas Spine, Bone Healing, Craniomaxillofacial and Thoracic (CMF), and Dental. It designs, manufactures, and markets orthopaedic reconstructive products, such as knee and hip reconstructive products; S.E.T. products, including surgical, sports medicine, biologics, foot and ankle, extremities, and trauma products; dental products that include dental reconstructive implants, and dental prosthetic and regenerative products; and spine products comprising medical devices and surgical instruments.
Company Leadership JW
NN
Founded in 1941 in Tokyo, Japan, HOYA Corporation is a global technology and med-tech company, and a supplier of medical products. HOYA provides eyeglasses, medical endoscopes, intraocular lenses, optical lenses, and also provides key components for semiconductor devices, LCD panels, and hard disk drives.
Company Leadership PA
HS
NG
Accuray develops and manufactures advanced radiation oncology systems designed to deliver precise cancer treatment solutions. The company specializes in creating innovative medical devices that enable clinicians to target tumors with exceptional accuracy while minimizing exposure to surrounding healthy tissue. This focus on precision has shaped the organization's technical approach and product development strategy across its portfolio. The company's radiation oncology systems integrate sophisticated imaging, planning, and delivery technologies to support comprehensive cancer care. By combining real-time imaging capabilities with adaptive treatment planning, Accuray's platforms allow medical teams to adjust therapy in response to anatomical changes during treatment courses. This technological integration addresses a critical challenge in oncology: maintaining treatment efficacy while reducing potential side effects that can impact patient quality of life. Accuray serves hospitals, cancer treatment centers, and specialized radiation oncology facilities globally. The company's systems support treatment of various cancer types across different anatomical sites, from brain and head-and-neck tumors to thoracic and abdominal malignancies. Healthcare providers rely on Accuray's technology to expand their treatment capabilities and improve clinical outcomes for patients who might otherwise have limited options.
Company Leadership KT
MR
Frequently Asked Questions Regarding Neuronetics Top Executives and Leadership Team
Unlock more people and company data
